Colorectal cancer is the second leading cause of cancer death in the U.S., with over 152,000 cases and nearly 53,000 deaths estimated in 2024. Morning ...

Ask the Experts” also served as a kickoff event for Cleveland Clinic’s Palm Beach Ball, which takes place Feb. 22 at The ...

The US regulator has cleared Lumakras (sotorasib) in combination with Amgen's anti-EGFR antibody Vectibix (panitumumab) for ...

With extremely cold temperatures and snow in the forecast for Middle Tennessee and Southern Kentucky, AAA issued a warning ...

FDA approves a new treatment for KRAS G12C-mutated metastatic colorectal cancer, showing significant progression-free ...

We have yet to find the cure for cancer, but there are ways to treat the disease and mitigate your risk of dying from it - ...

The American Cancer Society reports a significant rise in cancer cases among women under 50, with an 82% higher incidence ...

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.

An Oxford company which uses AI to develop cancer treatments has achieved further validation for its approach to tackling multiple tumours. Oxford Drug Design's colorectal cancer model study on mice ...

In response, a Department of Health spokesperson said: "Action 7 of the Northern Ireland Cancer Strategy (2022-32) has ...